SCHEDULE: Craig Shore Amends InspireMD Stake to 3.5%

Craig Shore, a citizen of Israel and the United States, has filed an amendment to his Schedule 13D, reporting beneficial ownership of 3.5% of InspireMD, Inc.'s common stock.

Summary

• Craig Shore, a retired individual, filed an Amendment No. 1 to Schedule 13D regarding his beneficial ownership in InspireMD, Inc.
• He beneficially owns 1,484,505 shares of common stock, representing 3.5% of the class.
• This aggregate amount consists of 1,066,799 common shares and options to purchase 417,706 shares exercisable within 60 days.
• The percentage is based on 41,720,662 shares outstanding as of August 4, 2025, as reported by InspireMD, Inc. in its Form 10-Q for the quarter ended June 30, 2025.
• The shares and options were granted pursuant to the InspireMD, Inc. 2013 Long-Term Incentive Plan and the 2021 Equity Incentive Plan.
• Shore has sole voting and dispositive power over these shares.
• He currently has no present plans or proposals for actions specified in Item 4 of Schedule 13D but may review his position, change his purpose, or acquire/dispose of shares in the future.

Sentiment

Score: 6

Explanation: The filing is neutral to slightly positive. It confirms a significant individual shareholder's continued stake, which can be seen as a vote of confidence. However, it also notes the shareholder's right to change their position or dispose of shares, introducing a minor element of uncertainty. No major positive or negative news is disclosed.

Positives

• A significant individual shareholder, Craig Shore, maintains a substantial stake of 3.5% in InspireMD, Inc., indicating continued personal investment.
• The shares and options were granted under the company's long-term incentive plans, aligning the reporting person's interests with the company's performance.

Risks

• The reporting person may, at any time, review or reconsider his position, change his purpose, or formulate new plans or proposals regarding the Issuer.
• The reporting person may acquire additional shares or dispose of some or all of his beneficially owned shares in the open market or privately negotiated transactions, which could impact share price.

Future Outlook

The reporting person currently has no present plans or proposals for actions specified in Item 4 of Schedule 13D but reserves the right to review his position, change his purpose, or formulate new plans or proposals, including acquiring or disposing of additional shares, at any time.

Industry Context

This filing is a routine disclosure of a significant shareholder's stake and does not provide specific industry context or trends. It reflects an individual's ongoing investment in the company.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant individual shareholder's stake and potential future actions, which could influence market perception.

Next Steps

• The reporting person may, at any time, review or reconsider his position in the Issuer.
• The reporting person may change his purpose or formulate plans or proposals with respect to his investment.
• The reporting person may propose or consider one or more actions described in clauses (a) through (j) of Item 4 to Schedule 13D.
• The reporting person may acquire beneficial ownership of additional shares or other securities of the Issuer.
• The reporting person may dispose of some or all of the shares beneficially owned in the open market or privately negotiated transactions.

Key Dates

Recommendation

This Schedule 13D amendment primarily serves as a disclosure of an existing significant beneficial ownership stake by Craig Shore. It does not contain new financial performance data, strategic shifts, or material events that would warrant a change in investment recommendation. The reporting person's stated intent to potentially acquire or dispose of shares in the future is a standard disclosure and does not provide a clear directional signal for immediate action. Therefore, a 'hold' recommendation is appropriate, awaiting further operational or strategic updates from InspireMD, Inc. itself.

Keywords

InspireMD, Inc., Craig Shore, Schedule 13D, Beneficial Ownership, Common Stock, Equity Incentive Plan, Shareholder